Long-Term Colestyramine Treatment Prevents Cholestatic Attacks in Refractory Benign Recurrent Intrahepatic Cholestasis Type 1 Disease.

• Authors: Eleni Koukoulioti, Athanasia Ziagaki, Susanne N Weber, Frank Lammert, Thomas Berg
• Journal: Hepatology (Baltimore, Md.) (Hepatology) Vol. 74 Issue 1 Pg. 522-524 (07 2021) ISSN: 1527-3350 [Electronic] United States
• PMID: 33277690 (Publication Type: Case Reports, Journal Article)

Chemical References

• Cholestyramine Resin

Topics

• Administration, Oral
• Cholestasis, Intrahepatic (drug therapy)
• Cholestyramine Resin (administration & dosage)
• Drug Resistance
• Humans
• Male
• Middle Aged
• Patient Acuity
• Recurrence
• Secondary Prevention (methods)
• Treatment Outcome